AmericansStill Believe Myths About Alzheimer’s Disease (NAPSA)—Arecent survey suggests that many Americans still regard Alzheimer’s disease as a natural consequence of aging. Eighty-seven percent of the 1,000 adults surveyed said they believe the “aging process” can cause or contribute to the development of Alzheimer’s disease and other types of dementia. However, while advanced ageis indeed a risk factor for the pro- gressive brain disease that robs individuals of their unique memo- ries and personalities, there is nothing natural about it—and there are ways to fight back. There are medications available today, such as Reminyl (galanta- Alzheimer’s disease can’t be cured, but it can be treated with medication, physical therapy, diet, psychological counseling and activity programs. toms, and may allow many pa- American adults were unaware of this fact. mine hydrobromide), that can slow the progression of the symp- tients more quality time with their loved ones. Alzheimer’s disease is a slow progressive disease of the brain. The 10 warning signs include the recent development of problems such as: 1. Difficulty remembering recent events and conversations. 2. Difficulty performing familiar tasks. 3. Problemsin finding the correct words to use in conversation. 4. Disorientation regarding time andplace. 5. Poor judgment. 6. Difficulty with abstract thinking. 7. A tendency to misplace things. 8. Changes in mood or behavior. 9. Changesin personality. 10. Loss ofinitiative. Alzheimer’s disease is just one form of dementia. Similar symptoms also can be caused by cere- brovascular disease, particularly one or more small strokes. However, in the survey, 17 percent of “This survey reinforces the continuing need for education, among both the general public and the medical community, on many aspects of dementia—includingits risk factors and available treatments,” notes Elizabeth Rimmer, executive director for Alzheimer’s Disease International (ADI). The ADI provided expert consultation for the survey, which was funded by Janssen Pharmaceutical Products, L.P, the marketer of Reminyl, the newest available drug for the treatment of mild to moderate Alzheimer’s disease. The most common side effects of Reminyl include nausea, vomiting, diarrhea, anorexia and weight loss. They are usually mild and temporary. For more information including full prescribing information, visit www.reminyl.com or call 1-866- REMINYL (1-866-736-4695). You also can learn more about Janssen’s support program for family caregivers, SharingCare’”, at www.sharingcare.com.
